Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.

Sen S, Talukdar I, Liu Y, Tam J, Reddy S, Webster NJ.

J Biol Chem. 2010 Aug 13;285(33):25426-37. doi: 10.1074/jbc.M109.095224. Epub 2010 Jun 2.

2.

Deciphering the splicing code.

Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ, Frey BJ.

Nature. 2010 May 6;465(7294):53-9. doi: 10.1038/nature09000.

PMID:
20445623
3.

Expansion of the eukaryotic proteome by alternative splicing.

Nilsen TW, Graveley BR.

Nature. 2010 Jan 28;463(7280):457-63. doi: 10.1038/nature08909. Review.

4.

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, Ares M Jr.

Nat Struct Mol Biol. 2010 Feb;17(2):187-93. doi: 10.1038/nsmb.1720. Epub 2010 Jan 24.

5.

MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.

Goers ES, Purcell J, Voelker RB, Gates DP, Berglund JA.

Nucleic Acids Res. 2010 Apr;38(7):2467-84. doi: 10.1093/nar/gkp1209. Epub 2010 Jan 13.

6.

RNA processing and its regulation: global insights into biological networks.

Licatalosi DD, Darnell RB.

Nat Rev Genet. 2010 Jan;11(1):75-87. doi: 10.1038/nrg2673. Review.

7.

Role of RNA structure in regulating pre-mRNA splicing.

Warf MB, Berglund JA.

Trends Biochem Sci. 2010 Mar;35(3):169-78. doi: 10.1016/j.tibs.2009.10.004. Epub 2009 Dec 1. Review.

8.

The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.

Warf MB, Diegel JV, von Hippel PH, Berglund JA.

Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9203-8. doi: 10.1073/pnas.0900342106. Epub 2009 May 26.

9.

The spliceosome: design principles of a dynamic RNP machine.

Wahl MC, Will CL, Lührmann R.

Cell. 2009 Feb 20;136(4):701-18. doi: 10.1016/j.cell.2009.02.009. Review.

10.

Solution structure of the RNA binding domain in the human muscleblind-like protein 2.

He F, Dang W, Abe C, Tsuda K, Inoue M, Watanabe S, Kobayashi N, Kigawa T, Matsuda T, Yabuki T, Aoki M, Seki E, Harada T, Tomabechi Y, Terada T, Shirouzu M, Tanaka A, Güntert P, Muto Y, Yokoyama S.

Protein Sci. 2009 Jan;18(1):80-91. doi: 10.1002/pro.17.

11.

Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition.

Yu Y, Maroney PA, Denker JA, Zhang XH, Dybkov O, Lührmann R, Jankowsky E, Chasin LA, Nilsen TW.

Cell. 2008 Dec 26;135(7):1224-36. doi: 10.1016/j.cell.2008.10.046.

12.

Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Holt I, Jacquemin V, Fardaei M, Sewry CA, Butler-Browne GS, Furling D, Brook JD, Morris GE.

Am J Pathol. 2009 Jan;174(1):216-27. doi: 10.2353/ajpath.2009.080520. Epub 2008 Dec 18. Erratum in: Am J Pathol. 2009 Mar;174(3):1120-1.

13.

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, Cooper TA.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20333-8. doi: 10.1073/pnas.0809045105. Epub 2008 Dec 15.

14.

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ.

Nat Genet. 2008 Dec;40(12):1413-5. doi: 10.1038/ng.259. Epub 2008 Nov 2. Erratum in: Nat Genet. 2009 Jun;41(6):762.

PMID:
18978789
15.

Alternative isoform regulation in human tissue transcriptomes.

Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB.

Nature. 2008 Nov 27;456(7221):470-6. doi: 10.1038/nature07509.

16.

Zebrafish muscleblind-like genes: identification, structural features and expression.

Liu YF, Liu HY, Tu LC, Lin CW, Hsiao KM, Pan H.

Comp Biochem Physiol B Biochem Mol Biol. 2008 Sep;151(1):118-24. doi: 10.1016/j.cbpb.2008.06.005. Epub 2008 Jun 12.

PMID:
18606240
17.

Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.

Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Cooper TA.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2646-51. doi: 10.1073/pnas.0708519105. Epub 2008 Feb 13.

18.

Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.

Hao M, Akrami K, Wei K, De Diego C, Che N, Ku JH, Tidball J, Graves MC, Shieh PB, Chen F.

Dev Dyn. 2008 Feb;237(2):403-10. doi: 10.1002/dvdy.21428.

19.
20.

Myotonic dystrophy: RNA-mediated muscle disease.

Wheeler TM, Thornton CA.

Curr Opin Neurol. 2007 Oct;20(5):572-6. Review.

PMID:
17885447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk